New research reveals the evasion mechanism of Porphyromonas gingivalis using CD47 and thrombospondin-1, which allows the bacterium to survive in inflamed tissues and increase the risk of systemic diseases.
A new study, led by Professor Gabriel Nussbaum of the Faculty of Dentistry at the Hebrew University, has discovered a new immune evasion mechanism of Porphyromonas gingivalis. The study, published in PNAS, explains how the pathogen exploits the CD47 protein – which functions as a “don’t eat me” signal – to interfere with immune signaling pathways and prevent its destruction. It was also found that the bacterium encourages the production of TSP-1, another product that suppresses the activity of neutrophils in removing bacteria.
Using in vitro and in vivo models, blocking CD47 or TSP-1 has been shown to significantly enhance the immune system's ability to clear the bacteria. Experiments with mice lacking CD47 have shown an increased ability to clear the body of P. gingivalis, suggesting that targeting this pathway may be a promising therapeutic approach for periodontal disease.
"Our findings suggest that P. gingivalis exploits CD47 to bypass immune signaling pathways, thereby preventing the immune system from clearing the infection," said Professor Nussbaum. "Understanding this mechanism could open the way to novel therapies that may not only combat local infection but also reduce the risk of systemic diseases such as heart disease, Alzheimer's and cancer."
With the strong link between periodontal disease and systemic diseases, the study provides important insights that could change future treatment approaches and lead to the development of new drugs to improve the immune response in chronic diseases.
More of the topic in Hayadan:
One response
It would be nice to give a little introduction to: In a new study, led by Professor Gabriel Nussbaum of the Faculty of Dentistry *at the Hebrew University of Jerusalem*.